ProMIS Neurosciences (PMN) Stock Chart & Stock Price History $0.69 -0.04 (-5.48%) Closing price 03:58 PM EasternExtended Trading$0.69 +0.00 (+0.14%) As of 05:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends ProMIS Neurosciences Stock Price Performance 5 Day Performance-9.92%1 Month Performance-21.23%3 Month Performance-23.59%6 Month Performance-43.90%Year-To-Date Performance-27.20%1 Year Performance-64.80% Receive PMN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ProMIS Neurosciences and its competitors with MarketBeat's FREE daily newsletter. Email Address PMN Stock Chart for Wednesday, March, 19, 2025 PMN Chart by TradingViewRemove Ads ProMIS Neurosciences Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization03/19/2025$0.72$0.69-3.50%$0.77$0.6322,806 shs$22.56 million03/18/2025$0.74$0.72-2.72%$0.77$0.7021,719 shs$23.37 million03/17/2025$0.77$0.74-4.05%$0.79$0.7318,847 shs$24.03 million03/14/2025$0.79$0.77-3.16%$0.79$0.7315,637 shs$25.04 million03/13/2025$0.76$0.79+3.81%$0.79$0.774,039 shs$25.86 million03/12/2025$0.75$0.76+2.28%$0.77$0.7410,395 shs$24.91 million03/11/2025$0.78$0.75-4.49%$0.78$0.723,411 shs$24.35 million03/10/2025$0.77$0.78+1.43%$0.79$0.7558,135 shs$25.50 million03/07/2025$0.73$0.77+5.63%$0.80$0.6744,616 shs$25.14 million03/06/2025$0.78$0.73-6.43%$0.78$0.7043,910 shs$23.80 million Get the Latest News and Ratings for PMN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ProMIS Neurosciences and its competitors with MarketBeat's FREE daily newsletter. 03/05/2025$0.78$0.78-0.13%$0.87$0.6958,168 shs$25.43 million03/04/2025$0.70$0.78+11.29%$0.78$0.6710,835 shs$25.47 million03/03/2025$0.73$0.70-4.50%$0.76$0.6251,045 shs$22.88 million02/28/2025$0.74$0.73-0.27%$0.79$0.7025,616 shs$23.96 million02/27/2025$0.75$0.74-2.00%$0.79$0.70106,733 shs$24.03 million02/26/2025$0.75$0.75-0.09%$0.82$0.6571,548 shs$24.52 million02/25/2025$0.80$0.75-6.19%$0.84$0.75107,554 shs$24.54 million02/24/2025$0.82$0.80-1.82%$0.84$0.8065,851 shs$26.16 million02/21/2025$0.90$0.82-9.45%$0.90$0.8029,889 shs$26.64 million02/20/2025$0.88$0.90+2.75%$0.91$0.8221,204 shs$29.42 million02/19/2025$0.90$0.88-2.67%$0.94$0.81101,336 shs$28.64 million02/18/2025$0.95$0.90-5.26%$0.93$0.9045,221 shs$29.42 million Related Companies Caribou Biosciences Stock Price Chart Ventyx Biosciences Stock Price Chart Invivyd Stock Price Chart TScan Therapeutics Stock Price Chart Vigil Neuroscience Stock Price Chart Atossa Therapeutics Stock Price Chart Black Diamond Therapeutics Stock Price Chart Climb Bio Stock Price Chart DBV Technologies Stock Price Chart Pliant Therapeutics Stock Price Chart Receive PMN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ProMIS Neurosciences and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PMN) was last updated on 3/19/2025 by MarketBeat.com Staff From Our PartnersElon Musk Wants to Audit Fort Knox—What It Means for Your RetirementYou can take advantage of the coming tariff-fueled gold melt-up right inside your IRA or 401(k) – 100% TAX-FRE...Colonial Metals | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProMIS Neurosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ProMIS Neurosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.